221 related articles for article (PubMed ID: 25799396)
1. Dyslipidemia and chronic inflammation markers are correlated with telomere length shortening in Cushing's syndrome.
Aulinas A; Ramírez MJ; Barahona MJ; Valassi E; Resmini E; Mato E; Santos A; Crespo I; Bell O; Surrallés J; Webb SM
PLoS One; 2015; 10(3):e0120185. PubMed ID: 25799396
[TBL] [Abstract][Full Text] [Related]
2. Telomere length analysis in Cushing's syndrome.
Aulinas A; Ramírez MJ; Barahona MJ; Valassi E; Resmini E; Mato E; Santos A; Crespo I; Bell O; Surrallés J; Webb SM
Eur J Endocrinol; 2014 Jul; 171(1):21-9. PubMed ID: 24743394
[TBL] [Abstract][Full Text] [Related]
3. Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome.
Barahona MJ; Sucunza N; Resmini E; Fernández-Real JM; Ricart W; Moreno-Navarrete JM; Puig T; Farrerons J; Webb SM
J Clin Endocrinol Metab; 2009 Sep; 94(9):3365-71. PubMed ID: 19509101
[TBL] [Abstract][Full Text] [Related]
4. Plasma adiponectin levels are related to obesity, inflammation, blood lipids and insulin in type 2 diabetic and non-diabetic Trinidadians.
Nayak BS; Ramsingh D; Gooding S; Legall G; Bissram S; Mohammed A; Raychaudhuri A; Sahadeo B; Pandohie V; Figaro K
Prim Care Diabetes; 2010 Oct; 4(3):187-92. PubMed ID: 20580627
[TBL] [Abstract][Full Text] [Related]
5. [Cardiovascular risk and inflammatory markers in patients with hypertension].
Krzesiński P; Hałas K; Gielerak G; Piotrowicz K; Stańczyk A; Piechota W; Jannasz I; Niedolaz K; Wojdat M; Skrobowski A
Pol Merkur Lekarski; 2015 Feb; 38(224):70-6. PubMed ID: 25771514
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome.
Santos A; Resmini E; Gómez-Ansón B; Crespo I; Granell E; Valassi E; Pires P; Vives-Gilabert Y; Martínez-Momblán MA; de Juan M; Mataró M; Webb SM
Eur J Endocrinol; 2015 Dec; 173(6):765-75. PubMed ID: 26497546
[TBL] [Abstract][Full Text] [Related]
7. Accelerated telomere shortening in leukocyte subpopulations of patients with coronary heart disease: role of cytomegalovirus seropositivity.
Spyridopoulos I; Hoffmann J; Aicher A; Brümmendorf TH; Doerr HW; Zeiher AM; Dimmeler S
Circulation; 2009 Oct; 120(14):1364-72. PubMed ID: 19770396
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory markers in hypertensive patients and influence of some associated metabolic risk factor.
Mitu F; Rezuş E; Banu C; Jufă C; Mitu O; Dima-Cozma C
Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):631-6. PubMed ID: 25341276
[TBL] [Abstract][Full Text] [Related]
9. Telomere length and type 2 diabetes in males, a premature aging syndrome.
Murillo-Ortiz B; Albarrán-Tamayo F; Arenas-Aranda D; Benítez-Bribiesca L; Malacara-Hernández JM; Martínez-Garza S; Hernández-González M; Solorio S; Garay-Sevilla ME; Mora-Villalpando C
Aging Male; 2012 Mar; 15(1):54-8. PubMed ID: 21824049
[TBL] [Abstract][Full Text] [Related]
10. Enhanced oxidative stress and platelet activation in patients with Cushing's syndrome.
Karamouzis I; Berardelli R; D'Angelo V; Fussotto B; Zichi C; Giordano R; Settanni F; Maccario M; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2015 Apr; 82(4):517-24. PubMed ID: 24923553
[TBL] [Abstract][Full Text] [Related]
11. Rotation thromboelastometry and the hypercoagulable state in Cushing's syndrome.
Coelho MC; Vieira Neto L; Kasuki L; Wildemberg LE; Santos CV; Castro G; Gouvêa G; Veloso OC; Gadelha T; Gadelha MR
Clin Endocrinol (Oxf); 2014 Nov; 81(5):657-64. PubMed ID: 24815846
[TBL] [Abstract][Full Text] [Related]
12. Increased osteoprotegerin levels in Cushing's syndrome are associated with an adverse cardiovascular risk profile.
Dovio A; Allasino B; Palmas E; Ventura M; Pia A; Saba L; Aroasio E; Terzolo M; Angeli A
J Clin Endocrinol Metab; 2007 May; 92(5):1803-8. PubMed ID: 17327380
[TBL] [Abstract][Full Text] [Related]
13. Waist circumference is positively correlated with markers of inflammation and negatively with adiponectin in women with metabolic syndrome.
Ackermann D; Jones J; Barona J; Calle MC; Kim JE; LaPia B; Volek JS; McIntosh M; Kalynych C; Najm W; Lerman RH; Fernandez ML
Nutr Res; 2011 Mar; 31(3):197-204. PubMed ID: 21481713
[TBL] [Abstract][Full Text] [Related]
14. Telomere length as a marker of cellular aging is associated with prevalence and progression of metabolic syndrome.
Révész D; Milaneschi Y; Verhoeven JE; Penninx BW
J Clin Endocrinol Metab; 2014 Dec; 99(12):4607-15. PubMed ID: 25188715
[TBL] [Abstract][Full Text] [Related]
15. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients.
Kopp HP; Kopp CW; Festa A; Krzyzanowska K; Kriwanek S; Minar E; Roka R; Schernthaner G
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1042-7. PubMed ID: 12714437
[TBL] [Abstract][Full Text] [Related]
16. Serum high sensitivity C-reactive protein, nitric oxide metabolites, plasma fibrinogen, and lipid parameters in Indian type 2 diabetic males.
Sarangi R; Padhi S; Mohapatra S; Swain S; Padhy RK; Mandal MK; Patro SK; Kumar S
Diabetes Metab Syndr; 2012; 6(1):9-14. PubMed ID: 23014248
[TBL] [Abstract][Full Text] [Related]
17. Zinc alpha-2 glycoprotein is overproduced in Cushing's syndrome.
Escoté X; Aranda GB; Mora M; Casals G; Enseñat J; Vidal O; Esteban Y; Halperin I; Hanzu FA
Endocrinol Diabetes Nutr; 2017 Jan; 64(1):26-33. PubMed ID: 28440767
[TBL] [Abstract][Full Text] [Related]
18. Stressful life events and leucocyte telomere length: Do lifestyle factors, somatic and mental health, or low grade inflammation mediate this relationship? Results from a cohort of Danish men born in 1953.
Osler M; Bendix L; Rask L; Rod NH
Brain Behav Immun; 2016 Nov; 58():248-253. PubMed ID: 27470228
[TBL] [Abstract][Full Text] [Related]
19. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
[TBL] [Abstract][Full Text] [Related]
20. Persistent centripetal fat distribution and metabolic abnormalities in patients in long-term remission of Cushing's syndrome.
Wagenmakers M; Roerink S; Gil L; Plantinga T; Smit J; Netea-Maier R; Hermus A
Clin Endocrinol (Oxf); 2015 Feb; 82(2):180-7. PubMed ID: 25323660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
